Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant Recipient (Kidney)”

903 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 903 results

Not applicableActive Not RecruitingNCT04747522
What this trial is testing

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)

Who this might be right for
Kidney Transplant InfectionSARS-CoV Infection
Oslo University Hospital 150
Post-approval studies (Phase 4)Study completedNCT00189150
What this trial is testing

Pharmacokinetics of Mmf and Valganciclovir

Who this might be right for
Kidney Transplant RecipientHeart Transplant Recipient
University of Michigan 16
Post-approval studies (Phase 4)Study completedNCT00319189
What this trial is testing

Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Who this might be right for
Renal Transplant RecipientsPosttransplant Diabetes MellitusPosttransplant Impaired Glucose Tolerance
University of Oslo School of Pharmacy 15
Post-approval studies (Phase 4)Ended earlyNCT00148252
What this trial is testing

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

Who this might be right for
Renal Transplantation
University of Oslo School of Pharmacy 298
Post-approval studies (Phase 4)Ended earlyNCT00522548
What this trial is testing

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Who this might be right for
Transplants and Implants
University of Pennsylvania 37
Not applicableStudy completedNCT01782209
What this trial is testing

BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

Who this might be right for
BK Virus (BKV) Viremia
University of Alabama at Birmingham 335
Testing effectiveness (Phase 2)UnknownNCT01837043
What this trial is testing

Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function

Who this might be right for
Delayed Graft FunctionKidney Transplant
Nair, Vinay, D.O. 90
Large-scale testing (Phase 3)Study completedNCT00248313
What this trial is testing

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer 470
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Post-approval studies (Phase 4)Study completedNCT00044720
What this trial is testing

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Who this might be right for
Chronic Kidney FailureGraft vs Host DiseaseKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 484
Post-approval studies (Phase 4)Ended earlyNCT02057523
What this trial is testing

Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients

Who this might be right for
ProteinuriaTransplant Glomerulopathy
University of Illinois at Chicago 2
Not applicableStudy completedNCT02639949
What this trial is testing

Measuring and Improving Medication Adherence in Kidney Transplant Patients

Who this might be right for
Kidney Transplant Recipients
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45
Not applicableEnrolling By InvitationNCT06950931
What this trial is testing

Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).

Who this might be right for
Transplant Recipient (Kidney)Primary Kidney Transplantation
University Hospital, Martin 86
Not applicableStudy completedNCT02412345
What this trial is testing

Extracorporeal Shockwave Therapy in the Treatment for Erectile Dysfunction in Male Renal Transplant Recipients

Who this might be right for
Erectile DysfunctionRenal Transplant
University of Sao Paulo 20
Not applicableStudy completedNCT00614081
What this trial is testing

GFR Measurement With Contrast-enhanced Dynamic MRI

Who this might be right for
Transplantation, KidneyGraft Occlusion, Vascular
University Hospital, Bordeaux 71
Not applicableStudy completedNCT00857844
What this trial is testing

Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers

Who this might be right for
Complication of Transplanted Liver
Northwestern University 207
Post-approval studies (Phase 4)Study completedNCT01044303
What this trial is testing

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Who this might be right for
Transplant; Failure, Kidney
East Carolina University 32
Not applicableUnknownNCT05856929
What this trial is testing

Sexual Dysfunction After Renal Transplantation

Who this might be right for
Sexual Dysfunction
Xijing Hospital 500
Not applicableStudy completedNCT03933137
What this trial is testing

P-POSSUM Score and Length of Stay

Who this might be right for
Length of Stay
Indonesia University 225
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Load More Results